The Future of Analytical and Interpretative Toxicology: Where are We Going and How Do We Get There?

被引:6
作者
Wille, Sarah M. R. [1 ]
Elliott, Simon [2 ,3 ]
机构
[1] Natl Inst Criminalist & Criminol, Dept Toxicol, Brussels, Belgium
[2] Elliott Forens Consulting Ltd, Birmingham, W Midlands, England
[3] Kings Coll London, Dept Analyt Environm & Forens Sci, London, England
关键词
DEPENDENT POSTMORTEM REDISTRIBUTION; ALTERNATIVE MATRICES; DRUG-INTERACTIONS; PSYCHOACTIVE SUBSTANCES; ACUTE INTOXICATION; POTENTIAL MARKERS; OPIOID WITHDRAWAL; BAYESIAN NETWORK; BLOOD-SAMPLES; PHARMACOGENETICS;
D O I
10.1093/jat/bkaa133
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
(Forensic) toxicology has faced many challenges, both analytically and interpretatively, especially in relation to an increase in potential drugs of interest. Analytical toxicology and its application to medicine and forensic science have progressed rapidly within the past centuries. Technological innovations have enabled detection of more substances with increasing sensitivity in a variety of matrices. Our understanding of the effects (both intended and unintended) have also increased along with determination and degree of toxicity. However, it is clear there is even more to understand and consider. The analytical focus has been on typical matrices such as blood and urine but other matrices could further increase our understanding, especially in postmortem (PM) situations. Within this context, the role of PM changes and potential redistribution of drugs requires further research and identification of markers of its occurrence and extent. Whilst instrumentation has improved, in the future, nanotechnology may play a role in selective and sensitive analysis as well as bioassays. Toxicologists often only have an advisory impact on pre-analytical and pre-interpretative considerations. The collection of appropriate samples at the right time in an appropriate way as well as obtaining sufficient circumstance background is paramount in ensuring an effective analytical strategy to provide useful results that can be interpreted within context. Nevertheless, key interpretative considerations such as pharmacogenomics and drug-drug interactions as well as determination of tolerance remain and in the future, analytical confirmation of an individual's metabolic profile may support a personalized medicine and judicial approach. This should be supported by the compilation and appropriate application of drug data pursuant to the situation. Specifically, in PM circumstances, data pertaining to where a drug was not/may have been/was contributory will be beneficial with associated pathological considerations. This article describes the challenges faced within toxicology and discusses progress to a future where they are being addressed.
引用
收藏
页码:619 / 632
页数:14
相关论文
共 124 条
[71]   Post-mortem toxicology: A pilot study to evaluate the use of a Bayesian network to assess the likelihood of fatality [J].
Langford, Alan M. ;
Bolton, Jennifer R. ;
Carlin, Michelle G. ;
Palmer, Ray .
JOURNAL OF FORENSIC AND LEGAL MEDICINE, 2015, 33 :82-90
[72]   Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma [J].
Launiainen, Terhi ;
Ojanpera, Ilkka .
DRUG TESTING AND ANALYSIS, 2014, 6 (04) :308-316
[73]   Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood [J].
Levo, A ;
Koski, A ;
Ojanperä, I ;
Vuori, E ;
Sajantila, A .
FORENSIC SCIENCE INTERNATIONAL, 2003, 135 (01) :9-15
[74]   Drug interactions with st John's Wort - Mechanisms and clinical implications [J].
Mannel, M .
DRUG SAFETY, 2004, 27 (11) :773-797
[75]   Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy [J].
Mannheimer, Buster ;
von Bahr, Christer ;
Pettersson, Hans ;
Eliasson, Erik .
THERAPEUTIC DRUG MONITORING, 2008, 30 (05) :565-569
[76]   Studies on drug metabolism by fungi colonizing decomposing human cadavers. Part II: biotransformation of five model drugs by fungi isolated from post-mortem material [J].
Martinez-Ramirez, Jorge A. ;
Walther, Grit ;
Peters, Frank T. .
DRUG TESTING AND ANALYSIS, 2015, 7 (04) :265-279
[77]   Application of a Bayesian network to aid the interpretation of blood alcohol (ethanol) concentrations in air crashes [J].
Maskell, Peter D. ;
Jackson, Graham .
FORENSIC SCIENCE INTERNATIONAL, 2020, 308
[78]   Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting [J].
May, Benedict ;
Naqi, Husain A. ;
Tipping, Michael ;
Scott, Jenny ;
Husbands, Stephen M. ;
Blagbrough, Ian S. ;
Pudney, Christopher R. .
ANALYTICAL CHEMISTRY, 2019, 91 (20) :12971-12979
[79]   Now important are gender differences in pharmacokinetics? [J].
Meibohm, B ;
Beierle, I ;
Derendorf, H .
CLINICAL PHARMACOKINETICS, 2002, 41 (05) :329-342
[80]   Molecularly imprinted polymers for on-line extraction techniques [J].
Moein, Mohammad M. ;
Abdel-Rehim, Mohamed .
BIOANALYSIS, 2015, 7 (17) :2145-2153